Health & Medicine
FDA Eases Restrictions on Glaxo Diabetes Drug Avandia
U.S. Food and Drug Administration said Monday that it is removing some restrictions on the prescription of GlaxoSmithKline Plc's Avandia- a diabetes drug. The agency eased rules on the drug's use after studies showed that it doesn't increase heart attack risk.
Latest Research Articles
Steroid Injections During Pregnancy Can Up ADHD Risk
Asparagine found in Meat and Dairy Essential for Brain Development
ADHD Diagnosis and Medication Use Sharply Increased During the Last Decade: CDC
Casual Sex Associated with Depression; Study
Study Explores Fear of Pain
Sugary Drinks Increase Endometrial Cancer Risk in Post Menopausal Women
FDA Approves Johnson & Johnson's Olysio for Hepatitis C Virus Infection Treatment
Stem Cells from the Umbilical Cord Used to Grow Artificial Skin
Fear of Offending Others May Prompt Unhealthy Food Choices Around the Holidays
Excessive TV for Preschoolers can Stall Cognitive Development
Bigger Dishware May Cause Children to Overeat [VIDEO]
Obesity Linked with Low Ability to Detect Sweet, Bitter Foods




